Notably, butanoate/butyrate production can be enhanced after bariatric surgery 69, while favorable effects of butyrate have been proved on MASLD, including attenuating hepatic steatosis and inflammation while enhancing insulin sensitivity 70. The gene discussed is INS; the disease is fatty liver disease.